ARCHIVES

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

This article is from The Cancer Letter archive.

Vol. 22 No. 46 | November 29, 1996

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

March 26, 2010

NIH Establishes Women’s Health Office, Responds To Criticism

September 14, 1990

CDC To Award $23 Mil. To States for Screening

April 26, 1991

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

Phase III Trial Demonstrates Early Docetaxel Combined With ADT Can Extend Survival

December 27, 2013